Enanta (ENTA) Worth Watching: Stock Rises 13.4% - Tale of the Tape
2014年2月3日 - 11:46PM
Zacks
Enanta Pharmaceuticals,
Inc. (ENTA) was a big mover last session with its shares
rising over 13% on the day. The move came on solid volume too with
far more shares changing hands than in a normal session. This
continues the recent uptrend of the company, as the stock is now up
nearly 27% in the past one-month time frame.
This biotechnology company has seen no estimate revision in the
last 7 days. However, the Zacks Consensus Estimate has moved higher
over the same period. This implies solid trading potential for the
company. So make sure to keep an eye on this stock going forward to
see if Friday’s rally can turn into more strength down the
road.
Enanta Pharmaceuticals currently has a Zacks Rank #3 (Hold) while
its Earnings ESP is 0.00%.
Some better-ranked retail stocks include Lannett Company,
Inc. (LCI), Endocyte, Inc. (ECYT) and
BioCryst Pharmaceuticals, Inc. (BCRX). While LCI
and ECYT sport a Zacks Rank #1 (Strong Buy), BCRX carries a Zacks
Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days. Click to get this free report >>
BIOCRYST PHARMA (BCRX): Free Stock Analysis Report
ENDOCYTE INC (ECYT): Free Stock Analysis Report
ENANTA PHARMA (ENTA): Free Stock Analysis Report
LANNETT INC (LCI): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
London Clubs (AMEX:LCI)
過去 株価チャート
から 5 2024 まで 6 2024
London Clubs (AMEX:LCI)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Lannett CO (アメリカ証券取引所): 0 recent articles
その他のLondon Clubsニュース記事